84
Management
Figure 15. Adults With ASCVD and Hypertriglyceridemia
1
Identify and manage
secondary causes of
hypertriglyceridemia
Continued observation
Optimize diet, physical
activity, ETOH intake,
and weight management
1
AND
1
Maximize statin
and other LDL–C-
lowering therapies
to achieve LDL-C and
non–HDL-C goals
NO
NO
Adults with
hypertriglyceridemia*
and ASCVD
YES
YES
2b
Add icosapent ethyl
LDL-C <100 mg/dL and
non–HDL-C <130 mg/dL on
maximally tolerated statin
Persistent fasting
hypertriglyceridemia
≥150–499 mg/dL?
